All allergic disease ‐ childhood (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes all allergic disease ‐ childhood (incidence) compared with human milk feeding ‐ low‐risk infants (very low certainty).
1 finding from 1 review
Food allergy ‐ childhood (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes food allergy ‐ childhood (incidence) compared with cow's milk formula ‐ low‐risk infants (very low certainty).
1 finding from 1 review
Cow's milk allergy ‐ infancy (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes cow's milk allergy ‐ infancy (incidence) compared with cow's milk formula ‐ low‐risk infants (very low certainty).
1 finding from 1 review
Cow's milk allergy ‐ childhood (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes cow's milk allergy ‐ childhood (incidence) compared with cow's milk formula ‐ low‐risk infants (very low certainty).
1 finding from 1 review
Asthma ‐ childhood (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes asthma ‐ childhood (incidence) compared with human milk feeding ‐ low‐risk infants (very low certainty).
1 finding from 1 review
Eczema ‐ childhood (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes eczema ‐ childhood (incidence) compared with human milk feeding ‐ low‐risk infants (very low certainty).
1 finding from 1 review
Food allergy ‐ childhood (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes food allergy ‐ childhood (incidence) compared with human milk feeding ‐ low‐risk infants (very low certainty).
1 finding from 1 review
Cow's milk allergy ‐ infancy (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes cow's milk allergy ‐ infancy (incidence) compared with human milk feeding ‐ low‐risk infants (very low certainty).
1 finding from 1 review
Cow's milk allergy ‐ childhood (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes cow's milk allergy ‐ childhood (incidence) compared with human milk feeding ‐ low‐risk infants (very low certainty).
1 finding from 1 review
All allergic disease ‐ childhood (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes all allergic disease ‐ childhood (incidence) compared with cow's milk formula ‐ low‐risk infants (very low certainty).
1 finding from 1 review
Asthma ‐ childhood (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes asthma ‐ childhood (incidence) compared with cow's milk formula ‐ low‐risk infants (very low certainty).
1 finding from 1 review
Eczema ‐ childhood (incidence) · infants not selected for allergic disease risk.
It is very uncertain whether early short‐term feeding: hydrolysed formula changes eczema ‐ childhood (incidence) compared with cow's milk formula ‐ low‐risk infants (very low certainty).
1 finding from 1 review